> top > docs > PMC:7205724 > spans > 19731-20478 > annotations

PMC:7205724 / 19731-20478 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
665 62-71 Species denotes SARS-CoV2 Tax:2697049
679 214-218 Gene denotes ACE2 Gene:103231639
680 112-121 Species denotes SARS-CoV2 Tax:2697049
681 247-256 Species denotes SARS-CoV2 Tax:2697049
682 325-333 Species denotes SARS-CoV Tax:694009
683 407-416 Species denotes SARS-CoV2 Tax:2697049
684 475-483 Species denotes SARS-CoV Tax:694009
685 584-593 Species denotes SARS-CoV2 Tax:2697049
686 598-606 Species denotes SARS-CoV Tax:694009
687 101-110 Disease denotes infection MESH:D007239
688 257-266 Disease denotes infection MESH:D007239
689 455-464 Disease denotes infection MESH:D007239
690 545-554 Disease denotes infection MESH:D007239
691 190-192 CellLine denotes E6 CVCL:4582

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T147 193-198 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T148 683-691 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T139 62-66 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T140 101-110 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T141 112-116 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T142 247-251 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T143 257-266 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T144 325-333 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T145 407-411 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T146 455-464 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T147 475-483 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T148 545-554 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T149 584-588 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T150 598-606 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T233 90-92 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T234 185-198 http://purl.obolibrary.org/obo/CLO_0051719 denotes Vero E6 cells
T235 444-446 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T236 534-536 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T237 701-708 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T166 683-691 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T84 72-83 http://purl.obolibrary.org/obo/IDO_0000608 denotes replication
T85 101-110 http://purl.obolibrary.org/obo/IDO_0000586 denotes infection
T86 122-133 http://purl.obolibrary.org/obo/IDO_0000608 denotes replication
T87 193-198 http://purl.obolibrary.org/obo/CL_0000000 denotes cells
T88 232-243 http://purl.obolibrary.org/obo/IDO_0000467 denotes susceptible
T89 257-266 http://purl.obolibrary.org/obo/IDO_0000586 denotes infection
T90 300-311 http://purl.obolibrary.org/obo/IDO_0000608 denotes replication
T91 417-428 http://purl.obolibrary.org/obo/IDO_0000608 denotes replication
T92 455-464 http://purl.obolibrary.org/obo/IDO_0000586 denotes infection
T93 545-554 http://purl.obolibrary.org/obo/IDO_0000586 denotes infection
T94 701-708 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T108 683-691 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T186 62-71 Species denotes SARS-CoV2 NCBItxid:2697049
T187 112-121 Species denotes SARS-CoV2 NCBItxid:2697049
T188 247-256 Species denotes SARS-CoV2 NCBItxid:2697049
T189 325-333 Species denotes SARS-CoV NCBItxid:694009
T190 407-416 Species denotes SARS-CoV2 NCBItxid:2697049
T191 475-483 Species denotes SARS-CoV NCBItxid:694009
T192 584-593 Species denotes SARS-CoV2 NCBItxid:2697049
T193 598-606 Species denotes SARS-CoV NCBItxid:694009
T194 701-708 Species denotes viruses NCBItxid:10239

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T157 0-14 Sentence denotes 5.2 Rational:
T158 15-83 Sentence denotes Recombinant type I IFN can effectively inhibit SARS-CoV2 replication
T159 84-272 Sentence denotes In 24–48 h after infection, SARS-CoV2 replication reaches titer that causes the cytopathic effect in Vero E6 cells, which express ACE2 and thus are susceptible to SARS-CoV2 infection [25].
T160 273-339 Sentence denotes It is similar to the viral replication kinetics for SARS-CoV [25].
T161 340-470 Sentence denotes Pretreatment with recombinant type I IFN could effectively inhibit SARS-CoV2 replication at both 24 and 48 h after infection [25].
T162 471-560 Sentence denotes For SARS-CoV, such an effect was present at 24 h but absent at 48 h after infection [25].
T163 561-747 Sentence denotes The difference between SARS-CoV2 and SARS-CoV in response to type I IFN treatment may be due to differences in structural proteins of these viruses, including NSP3, ORF3b, and ORF6 [25].

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
665 62-71 Species denotes SARS-CoV2 Tax:2697049
687 101-110 Disease denotes infection MESH:D007239
680 112-121 Species denotes SARS-CoV2 Tax:2697049
691 190-192 CellLine denotes E6 CVCL:4582
679 214-218 Gene denotes ACE2 Gene:103231639
681 247-256 Species denotes SARS-CoV2 Tax:2697049
688 257-266 Disease denotes infection MESH:D007239
682 325-333 Species denotes SARS-CoV Tax:694009
683 407-416 Species denotes SARS-CoV2 Tax:2697049
689 455-464 Disease denotes infection MESH:D007239
684 475-483 Species denotes SARS-CoV Tax:694009
690 545-554 Disease denotes infection MESH:D007239
685 584-593 Species denotes SARS-CoV2 Tax:2697049
686 598-606 Species denotes SARS-CoV Tax:694009

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1989 672-691 Protein denotes structural proteins https://www.uniprot.org/uniprot/Q6LEG6|https://www.uniprot.org/uniprot/Q04766|https://www.uniprot.org/uniprot/Q04765
T1992 720-724 Protein denotes NSP3 https://www.uniprot.org/uniprot/Q9QNA7|https://www.uniprot.org/uniprot/Q9PY95|https://www.uniprot.org/uniprot/Q9ICB2|https://www.uniprot.org/uniprot/Q91ME7|https://www.uniprot.org/uniprot/Q8UZL8|https://www.uniprot.org/uniprot/Q8B6X8|https://www.uniprot.org/uniprot/Q8B6X7|https://www.uniprot.org/uniprot/Q86504|https://www.uniprot.org/uniprot/Q86196|https://www.uniprot.org/uniprot/Q85014|https://www.uniprot.org/uniprot/Q82054|https://www.uniprot.org/uniprot/Q82053|https://www.uniprot.org/uniprot/Q82052|https://www.uniprot.org/uniprot/Q82051|https://www.uniprot.org/uniprot/Q82050|https://www.uniprot.org/uniprot/Q82049|https://www.uniprot.org/uniprot/Q65701|https://www.uniprot.org/uniprot/Q5Y9A9|https://www.uniprot.org/uniprot/Q5K037|https://www.uniprot.org/uniprot/Q45UF3|https://www.uniprot.org/uniprot/Q3ZK63|https://www.uniprot.org/uniprot/Q27PP2|https://www.uniprot.org/uniprot/Q0H8C1|https://www.uniprot.org/uniprot/Q00721|https://www.uniprot.org/uniprot/P34717|https://www.uniprot.org/uniprot/P27586|https://www.uniprot.org/uniprot/P04514|https://www.uniprot.org/uniprot/P03536|https://www.uniprot.org/uniprot/B3SRX7|https://www.uniprot.org/uniprot/B3SRW9|https://www.uniprot.org/uniprot/B3SRV3|https://www.uniprot.org/uniprot/B3SRU5|https://www.uniprot.org/uniprot/B3SRS9|https://www.uniprot.org/uniprot/B3SRS1|https://www.uniprot.org/uniprot/B3SRR3|https://www.uniprot.org/uniprot/B3SRQ5|https://www.uniprot.org/uniprot/B2BRG4|https://www.uniprot.org/uniprot/A4ZCW4|https://www.uniprot.org/uniprot/A3DSK9|https://www.uniprot.org/uniprot/A2T3N5|https://www.uniprot.org/uniprot/A1YTU9
T2033 737-741 Protein denotes ORF6 https://www.uniprot.org/uniprot/P51707|https://www.uniprot.org/uniprot/P42541|https://www.uniprot.org/uniprot/P0DTC6

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T44068 0-3 CD denotes 5.2
T95208 5-13 NNP denotes Rational
T91019 13-14 -COLON- denotes :
T95927 15-26 JJ denotes Recombinant
T3712 27-31 NN denotes type
T46872 32-33 CD denotes I
T95232 34-37 NN denotes IFN
T83801 38-41 MD denotes can
T31121 42-53 RB denotes effectively
T50200 54-61 VB denotes inhibit
T51383 62-71 NN denotes SARS-CoV2
T97492 72-83 NN denotes replication
T96177 84-86 IN denotes In
T72452 87-94 NN denotes 24–48 h
T50493 95-100 IN denotes after
T17096 101-110 NN denotes infection
T97012 110-111 -COMMA- denotes ,
T67170 112-121 NN denotes SARS-CoV2
T9761 122-133 NN denotes replication
T69880 134-141 VBZ denotes reaches
T9709 142-147 NN denotes titer
T49785 148-152 WDT denotes that
T71708 153-159 VBZ denotes causes
T52777 160-163 DT denotes the
T56623 164-174 JJ denotes cytopathic
T87850 175-181 NN denotes effect
T47272 182-184 IN denotes in
T71726 185-189 NN denotes Vero
T42629 190-192 NN denotes E6
T73531 193-198 NNS denotes cells
T60353 198-199 -COMMA- denotes ,
T83400 200-205 WDT denotes which
T80948 206-213 VBP denotes express
T12338 214-218 NN denotes ACE2
T60658 219-222 CC denotes and
T41368 223-227 RB denotes thus
T89464 228-231 VBP denotes are
T62340 232-243 JJ denotes susceptible
T6873 244-246 TO denotes to
T68175 247-256 NN denotes SARS-CoV2
T16296 257-266 NN denotes infection
T12529 267-268 -LRB- denotes [
T55131 268-270 CD denotes 25
T28678 270-271 -RRB- denotes ]
T52876 273-275 PRP denotes It
T21084 276-278 VBZ denotes is
T70918 279-286 JJ denotes similar
T20327 287-289 TO denotes to
T13471 290-293 DT denotes the
T26039 294-299 JJ denotes viral
T64125 300-311 NN denotes replication
T62855 312-320 NNS denotes kinetics
T68614 321-324 IN denotes for
T64958 325-333 NN denotes SARS-CoV
T62199 334-335 -LRB- denotes [
T27403 335-337 CD denotes 25
T34963 337-338 -RRB- denotes ]
T49689 340-352 NN denotes Pretreatment
T74739 353-357 IN denotes with
T62356 358-369 JJ denotes recombinant
T67333 370-374 NN denotes type
T31833 375-376 CD denotes I
T78772 377-380 NN denotes IFN
T57406 381-386 MD denotes could
T5100 387-398 RB denotes effectively
T32529 399-406 VB denotes inhibit
T31501 407-416 NN denotes SARS-CoV2
T43668 417-428 NN denotes replication
T86722 429-431 IN denotes at
T26971 432-436 CC denotes both
T35627 437-439 CD denotes 24
T29701 440-443 CC denotes and
T48153 444-448 NN denotes 48 h
T93874 449-454 IN denotes after
T7550 455-464 NN denotes infection
T23827 465-466 -LRB- denotes [
T6071 466-468 CD denotes 25
T91011 468-469 -RRB- denotes ]
T51029 471-474 IN denotes For
T64526 475-483 NN denotes SARS-CoV
T41819 483-484 -COMMA- denotes ,
T5764 485-489 PDT denotes such
T79954 490-492 DT denotes an
T48924 493-499 NN denotes effect
T40034 500-503 VBD denotes was
T1935 504-511 JJ denotes present
T31311 512-514 IN denotes at
T94385 515-519 CD denotes 24 h
T84543 520-523 CC denotes but
T64490 524-530 JJ denotes absent
T33679 531-533 IN denotes at
T68271 534-538 NN denotes 48 h
T69307 539-544 IN denotes after
T51672 545-554 NN denotes infection
T85433 555-556 -LRB- denotes [
T72350 556-558 CD denotes 25
T63406 558-559 -RRB- denotes ]
T46096 561-564 DT denotes The
T71403 565-575 NN denotes difference
T17651 576-583 IN denotes between
T77482 584-593 NN denotes SARS-CoV2
T6733 594-597 CC denotes and
T6622 598-606 NN denotes SARS-CoV
T66580 607-609 IN denotes in
T74975 610-618 NN denotes response
T1853 619-621 TO denotes to
T87892 622-626 NN denotes type
T83308 627-628 CD denotes I
T81934 629-632 NN denotes IFN
T42652 633-642 NN denotes treatment
T91527 643-646 MD denotes may
T42839 647-649 VB denotes be
T98810 650-653 JJ denotes due
T31126 654-656 TO denotes to
T23141 657-668 NNS denotes differences
T45488 669-671 IN denotes in
T39296 672-682 JJ denotes structural
T12723 683-691 NNS denotes proteins
T40582 692-694 IN denotes of
T48639 695-700 DT denotes these
T20513 701-708 NNS denotes viruses
T37519 708-709 -COMMA- denotes ,
T18237 710-719 VBG denotes including
T17094 720-724 NN denotes NSP3
T86991 724-725 -COMMA- denotes ,
T14810 726-731 NN denotes ORF3b
T9269 731-732 -COMMA- denotes ,
T18064 733-736 CC denotes and
T40695 737-741 NN denotes ORF6
T59456 742-743 -LRB- denotes [
T34145 743-745 CD denotes 25
T98303 745-746 -RRB- denotes ]
R31420 T69880 T96177 arg1Of reaches,In
R8938 T72452 T96177 arg2Of 24–48 h,In
R22070 T72452 T50493 arg1Of 24–48 h,after
R29558 T17096 T50493 arg2Of infection,after
R81743 T69880 T97012 arg1Of reaches,","
R54619 T9761 T67170 arg1Of replication,SARS-CoV2
R28733 T9761 T69880 arg1Of replication,reaches
R54888 T9709 T69880 arg2Of titer,reaches
R54019 T9709 T49785 arg1Of titer,that
R2019 T9709 T71708 arg1Of titer,causes
R69166 T87850 T71708 arg2Of effect,causes
R70600 T87850 T52777 arg1Of effect,the
R54949 T87850 T56623 arg1Of effect,cytopathic
R12484 T95208 T44068 arg1Of Rational,5.2
R35124 T95208 T91019 arg1Of Rational,:
R50751 T95232 T95927 arg1Of IFN,Recombinant
R74572 T95232 T3712 arg1Of IFN,type
R58753 T95232 T46872 arg1Of IFN,I
R16030 T95232 T83801 arg1Of IFN,can
R78959 T50200 T83801 arg2Of inhibit,can
R77408 T50200 T31121 arg1Of inhibit,effectively
R98880 T95232 T50200 arg1Of IFN,inhibit
R90780 T97492 T50200 arg2Of replication,inhibit
R70416 T97492 T51383 arg1Of replication,SARS-CoV2
R67236 T71708 T47272 arg1Of causes,in
R90604 T73531 T47272 arg2Of cells,in
R51483 T73531 T71726 arg1Of cells,Vero
R13941 T73531 T42629 arg1Of cells,E6
R47369 T73531 T60353 arg1Of cells,","
R77344 T73531 T83400 arg1Of cells,which
R51996 T73531 T80948 arg1Of cells,express
R29937 T12338 T80948 arg2Of ACE2,express
R56727 T80948 T60658 arg1Of express,and
R89880 T89464 T60658 arg2Of are,and
R41139 T89464 T41368 arg1Of are,thus
R40674 T73531 T89464 arg1Of cells,are
R2313 T62340 T89464 arg2Of susceptible,are
R71574 T73531 T62340 arg1Of cells,susceptible
R18320 T62340 T6873 arg1Of susceptible,to
R10483 T16296 T6873 arg2Of infection,to
R64279 T16296 T68175 arg1Of infection,SARS-CoV2
R82228 T89464 T12529 arg1Of are,[
R14351 T55131 T12529 arg2Of 25,[
R89760 T28678 T12529 arg3Of ],[
R98431 T52876 T21084 arg1Of It,is
R14327 T70918 T21084 arg2Of similar,is
R4320 T52876 T70918 arg1Of It,similar
R34375 T70918 T20327 arg1Of similar,to
R71339 T62855 T20327 arg2Of kinetics,to
R35190 T62855 T13471 arg1Of kinetics,the
R34673 T62855 T26039 arg1Of kinetics,viral
R67158 T62855 T64125 arg1Of kinetics,replication
R90913 T70918 T68614 arg1Of similar,for
R5275 T64958 T68614 arg2Of SARS-CoV,for
R43068 T64958 T62199 arg1Of SARS-CoV,[
R10807 T27403 T62199 arg2Of 25,[
R91008 T34963 T62199 arg3Of ],[
R68776 T49689 T74739 arg1Of Pretreatment,with
R59690 T78772 T74739 arg2Of IFN,with
R64010 T78772 T62356 arg1Of IFN,recombinant
R73596 T78772 T67333 arg1Of IFN,type
R44930 T78772 T31833 arg1Of IFN,I
R49184 T49689 T57406 arg1Of Pretreatment,could
R80908 T32529 T57406 arg2Of inhibit,could
R7756 T32529 T5100 arg1Of inhibit,effectively
R41655 T49689 T32529 arg1Of Pretreatment,inhibit
R47659 T43668 T32529 arg2Of replication,inhibit
R36370 T43668 T31501 arg1Of replication,SARS-CoV2
R34213 T32529 T86722 arg1Of inhibit,at
R26206 T29701 T86722 arg2Of and,at
R82903 T29701 T26971 arg1Of and,both
R75547 T35627 T29701 arg1Of 24,and
R90827 T48153 T29701 arg2Of 48 h,and
R69068 T32529 T93874 arg1Of inhibit,after
R47977 T7550 T93874 arg2Of infection,after
R38076 T7550 T23827 arg1Of infection,[
R72421 T6071 T23827 arg2Of 25,[
R2860 T91011 T23827 arg3Of ],[
R21012 T40034 T51029 arg1Of was,For
R42425 T64526 T51029 arg2Of SARS-CoV,For
R88091 T40034 T41819 arg1Of was,","
R54495 T48924 T5764 arg1Of effect,such
R26625 T48924 T79954 arg1Of effect,an
R41534 T48924 T40034 arg1Of effect,was
R24883 T84543 T40034 arg2Of but,was
R86398 T48924 T1935 arg1Of effect,present
R81876 T1935 T31311 arg1Of present,at
R72270 T94385 T31311 arg2Of 24 h,at
R12851 T1935 T84543 arg1Of present,but
R60363 T64490 T84543 arg2Of absent,but
R81621 T48924 T64490 arg1Of effect,absent
R79664 T84543 T33679 arg1Of but,at
R9487 T68271 T33679 arg2Of 48 h,at
R71731 T68271 T69307 arg1Of 48 h,after
R56025 T51672 T69307 arg2Of infection,after
R2152 T51672 T85433 arg1Of infection,[
R22284 T72350 T85433 arg2Of 25,[
R9566 T63406 T85433 arg3Of ],[
R51347 T71403 T46096 arg1Of difference,The
R4839 T71403 T17651 arg1Of difference,between
R32316 T6733 T17651 arg2Of and,between
R84108 T77482 T6733 arg1Of SARS-CoV2,and
R18562 T6622 T6733 arg2Of SARS-CoV,and
R2587 T6733 T66580 arg1Of and,in
R24267 T74975 T66580 arg2Of response,in
R82007 T74975 T1853 arg1Of response,to
R35751 T42652 T1853 arg2Of treatment,to
R70872 T42652 T87892 arg1Of treatment,type
R16675 T42652 T83308 arg1Of treatment,I
R93961 T42652 T81934 arg1Of treatment,IFN
R17630 T71403 T91527 arg1Of difference,may
R18684 T42839 T91527 arg2Of be,may
R22926 T71403 T42839 arg1Of difference,be
R74216 T31126 T42839 arg2Of to,be
R18552 T31126 T98810 arg1Of to,due
R78491 T71403 T31126 arg1Of difference,to
R99441 T23141 T31126 arg2Of differences,to
R87106 T23141 T45488 arg1Of differences,in
R95354 T12723 T45488 arg2Of proteins,in
R28120 T12723 T39296 arg1Of proteins,structural
R78454 T12723 T40582 arg1Of proteins,of
R26738 T20513 T40582 arg2Of viruses,of
R35077 T20513 T48639 arg1Of viruses,these
R70559 T12723 T37519 arg1Of proteins,","
R50810 T12723 T18237 arg1Of proteins,including
R8147 T18064 T18237 arg2Of and,including
R72409 T17094 T86991 arg1Of NSP3,","
R12802 T14810 T86991 arg2Of ORF3b,","
R29123 T18064 T9269 arg1Of and,","
R68379 T86991 T18064 arg1Of ",",and
R4978 T40695 T18064 arg2Of ORF6,and
R22872 T18064 T59456 arg1Of and,[
R60583 T34145 T59456 arg2Of 25,[
R50503 T98303 T59456 arg3Of ],[

LitCovid-sample-PD-GO-BP-0

Id Subject Object Predicate Lexical cue
T27 294-311 http://purl.obolibrary.org/obo/GO_0019058 denotes viral replication
T28 294-311 http://purl.obolibrary.org/obo/GO_0019079 denotes viral replication
T29 610-632 http://purl.obolibrary.org/obo/GO_0034340 denotes response to type I IFN

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T147 193-198 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T148 683-691 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T134 62-71 Disease denotes SARS-CoV2 http://purl.obolibrary.org/obo/MONDO_0100096
T135 101-110 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T136 112-121 Disease denotes SARS-CoV2 http://purl.obolibrary.org/obo/MONDO_0100096
T137 247-256 Disease denotes SARS-CoV2 http://purl.obolibrary.org/obo/MONDO_0100096
T138 257-266 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T139 325-333 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T140 407-416 Disease denotes SARS-CoV2 http://purl.obolibrary.org/obo/MONDO_0100096
T141 455-464 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T142 475-483 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T143 545-554 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T144 584-593 Disease denotes SARS-CoV2 http://purl.obolibrary.org/obo/MONDO_0100096
T145 598-606 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-sample-GO-BP

Id Subject Object Predicate Lexical cue
T23 294-311 http://purl.obolibrary.org/obo/GO_0019079 denotes viral replication
T24 294-311 http://purl.obolibrary.org/obo/GO_0019058 denotes viral replication
T25 610-632 http://purl.obolibrary.org/obo/GO_0034340 denotes response to type I IFN

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T23 294-311 http://purl.obolibrary.org/obo/GO_0019079 denotes viral replication
T24 294-311 http://purl.obolibrary.org/obo/GO_0019058 denotes viral replication
T25 610-632 http://purl.obolibrary.org/obo/GO_0034340 denotes response to type I IFN

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T157 0-14 Sentence denotes 5.2 Rational:
T158 15-83 Sentence denotes Recombinant type I IFN can effectively inhibit SARS-CoV2 replication
T159 84-272 Sentence denotes In 24–48 h after infection, SARS-CoV2 replication reaches titer that causes the cytopathic effect in Vero E6 cells, which express ACE2 and thus are susceptible to SARS-CoV2 infection [25].
T160 273-339 Sentence denotes It is similar to the viral replication kinetics for SARS-CoV [25].
T161 340-470 Sentence denotes Pretreatment with recombinant type I IFN could effectively inhibit SARS-CoV2 replication at both 24 and 48 h after infection [25].
T162 471-560 Sentence denotes For SARS-CoV, such an effect was present at 24 h but absent at 48 h after infection [25].
T163 561-747 Sentence denotes The difference between SARS-CoV2 and SARS-CoV in response to type I IFN treatment may be due to differences in structural proteins of these viruses, including NSP3, ORF3b, and ORF6 [25].